-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Freeline Therapeutics Holdings plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2022.
- Freeline Therapeutics Holdings plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2023 was 65.8M shares, a 54.2% increase year-over-year.
- Freeline Therapeutics Holdings plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 59.3M shares, a 66% increase from 2021.
- Freeline Therapeutics Holdings plc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 35.7M shares, a 152% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)